Please see below to view details for this session presenter

Matthew Winkler, PhD

Chief Executive Officer, Asuragen, Inc.

Dr. Winkler is the Founder and CEO of Asuragen, Inc, a molecular diagnostics firm based in Austin.  He is also the Founder of Mirna Therapeutics, a miRNA oncology therapeutics company. Prior to Asuragen, he was Founder and CEO of Ambion, an Austin-based molecular biology reagent company that was sold to Applied Biosystems for $273M in 2006 (now LIFE Technologies).  Dr. Winkler joined the University of Texas at Austin Zoology Department as an Assistant Professor in 1983 and was promoted to Associate Professor in 1988.  He received a BS in Genetics and a PhD in Zoology from the University of California at Berkeley.